This inventor holds 1 USPTO granted patent. Top assignee: Sungkyunkwan University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Byeong Hoon Oh: Innovator in Autoimmune Disease Treatment
Introduction
Byeong Hoon Oh is a prominent inventor based in Gwangyang-si, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach focuses on utilizing stem cell-derived exosomes to enhance therapeutic efficiency.
Latest Patents
Byeong Hoon Oh holds a patent for a composition aimed at preventing or treating inflammatory macrophage-mediated autoimmune diseases. The patent, titled "Composition for preventing or treating inflammatory macrophage-mediated autoimmune disease comprising exosomes derived from stem cells that are surface-modified to target activated macrophages," describes a composition that includes a stem cell-derived exosome modified with a sugar compound. This modification allows the composition to specifically target activated macrophages, thereby increasing therapeutic efficiency for various autoimmune diseases, including rheumatoid arthritis. The invention boasts a superior therapeutic effect while minimizing side effects compared to conventional treatments.
Career Highlights
Byeong Hoon Oh is affiliated with Sungkyunkwan University, where he continues to advance research in the field of autoimmune diseases. His work has garnered attention for its innovative approach and potential impact on treatment methodologies.
Collaborations
Byeong Hoon Oh has collaborated with notable colleagues, including Jae Hyung Park and Dong Gil You, to further enhance the research and development of his innovative compositions.
Conclusion
Byeong Hoon Oh's contributions to the field of autoimmune disease treatment through his patented innovations highlight the importance of research in improving therapeutic options. His work exemplifies the potential of stem cell technology in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
